Faecal microbial transfer and complex carbohydrates mediate protection against COPD.
Budden, KF
Shukla, SD
Bowerman, KL
Vaughan, A
Gellatly, SL
Wood, DLA
Lachner, N
Idrees, S
Rehman, SF
Faiz, A
Patel, VK
Donovan, C
Alemao, CA
Shen, S
Amorim, N
Majumder, R
Vanka, KS
Mason, J
Haw, TJ
Tillet, B
Fricker, M
Keely, S
Hansbro, N
Belz, GT
Horvat, J
Ashhurst, T
van Vreden, C
McGuire, H
Fazekas de St Groth, B
King, NJC
Crossett, B
Cordwell, SJ
Bonaguro, L
Schultze, JL
Hamilton-Williams, EE
Mann, E
Forster, SC
Cooper, MA
Segal, LN
Chotirmall, SH
Collins, P
Bowman, R
Fong, KM
Yang, IA
Wark, PAB
Dennis, PG
Hugenholtz, P
Hansbro, PM
- Publisher:
- BMJ PUBLISHING GROUP
- Publication Type:
- Journal Article
- Citation:
- Gut, 2024, 73, (5), pp. 751-769
- Issue Date:
- 2024-04-05
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Budden, KF | |
dc.contributor.author | Shukla, SD | |
dc.contributor.author | Bowerman, KL | |
dc.contributor.author |
Vaughan, A https://orcid.org/0000-0001-5890-7877 |
|
dc.contributor.author | Gellatly, SL | |
dc.contributor.author | Wood, DLA | |
dc.contributor.author | Lachner, N | |
dc.contributor.author |
Idrees, S https://orcid.org/0000-0001-8512-7593 |
|
dc.contributor.author | Rehman, SF | |
dc.contributor.author |
Faiz, A https://orcid.org/0000-0003-1740-3538 |
|
dc.contributor.author | Patel, VK | |
dc.contributor.author |
Donovan, C https://orcid.org/0000-0003-4558-329X |
|
dc.contributor.author | Alemao, CA | |
dc.contributor.author |
Shen, S https://orcid.org/0000-0002-1004-1936 |
|
dc.contributor.author | Amorim, N | |
dc.contributor.author |
Majumder, R https://orcid.org/0000-0002-7244-6058 |
|
dc.contributor.author | Vanka, KS | |
dc.contributor.author | Mason, J | |
dc.contributor.author | Haw, TJ | |
dc.contributor.author | Tillet, B | |
dc.contributor.author | Fricker, M | |
dc.contributor.author | Keely, S | |
dc.contributor.author |
Hansbro, N https://orcid.org/0000-0002-2371-7990 |
|
dc.contributor.author | Belz, GT | |
dc.contributor.author | Horvat, J | |
dc.contributor.author | Ashhurst, T | |
dc.contributor.author | van Vreden, C | |
dc.contributor.author | McGuire, H | |
dc.contributor.author | Fazekas de St Groth, B | |
dc.contributor.author | King, NJC | |
dc.contributor.author | Crossett, B | |
dc.contributor.author | Cordwell, SJ | |
dc.contributor.author | Bonaguro, L | |
dc.contributor.author | Schultze, JL | |
dc.contributor.author | Hamilton-Williams, EE | |
dc.contributor.author | Mann, E | |
dc.contributor.author | Forster, SC | |
dc.contributor.author | Cooper, MA | |
dc.contributor.author | Segal, LN | |
dc.contributor.author | Chotirmall, SH | |
dc.contributor.author | Collins, P | |
dc.contributor.author | Bowman, R | |
dc.contributor.author | Fong, KM | |
dc.contributor.author | Yang, IA | |
dc.contributor.author | Wark, PAB | |
dc.contributor.author | Dennis, PG | |
dc.contributor.author | Hugenholtz, P | |
dc.contributor.author | Hansbro, PM | |
dc.date.accessioned | 2024-09-15T03:51:00Z | |
dc.date.available | 2024-01-08 | |
dc.date.available | 2024-09-15T03:51:00Z | |
dc.date.issued | 2024-04-05 | |
dc.identifier.citation | Gut, 2024, 73, (5), pp. 751-769 | |
dc.identifier.issn | 0017-5749 | |
dc.identifier.issn | 1468-3288 | |
dc.identifier.uri | http://hdl.handle.net/10453/180823 | |
dc.description | Free online access at the publisher's site: https://doi.org/10.1136/gutjnl-2023-330521 | |
dc.description.abstract | OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a major cause of global illness and death, most commonly caused by cigarette smoke. The mechanisms of pathogenesis remain poorly understood, limiting the development of effective therapies. The gastrointestinal microbiome has been implicated in chronic lung diseases via the gut-lung axis, but its role is unclear. DESIGN: Using an in vivo mouse model of cigarette smoke (CS)-induced COPD and faecal microbial transfer (FMT), we characterised the faecal microbiota using metagenomics, proteomics and metabolomics. Findings were correlated with airway and systemic inflammation, lung and gut histopathology and lung function. Complex carbohydrates were assessed in mice using a high resistant starch diet, and in 16 patients with COPD using a randomised, double-blind, placebo-controlled pilot study of inulin supplementation. RESULTS: FMT alleviated hallmark features of COPD (inflammation, alveolar destruction, impaired lung function), gastrointestinal pathology and systemic immune changes. Protective effects were additive to smoking cessation, and transfer of CS-associated microbiota after antibiotic-induced microbiome depletion was sufficient to increase lung inflammation while suppressing colonic immunity in the absence of CS exposure. Disease features correlated with the relative abundance of Muribaculaceae, Desulfovibrionaceae and Lachnospiraceae family members. Proteomics and metabolomics identified downregulation of glucose and starch metabolism in CS-associated microbiota, and supplementation of mice or human patients with complex carbohydrates improved disease outcomes. CONCLUSION: The gut microbiome contributes to COPD pathogenesis and can be targeted therapeutically. | |
dc.format | Electronic | |
dc.language | eng | |
dc.publisher | BMJ PUBLISHING GROUP | |
dc.relation | http://purl.org/au-research/grants/nhmrc/GNT1079187 | |
dc.relation | http://purl.org/au-research/grants/nhmrc/1175134 | |
dc.relation | Free online access at publisher's site at: https://doi.org/10.1136/gutjnl-2023-330521 | |
dc.relation.ispartof | Gut | |
dc.relation.isbasedon | 10.1136/gutjnl-2023-330521 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine | |
dc.subject.classification | Gastroenterology & Hepatology | |
dc.subject.classification | 3202 Clinical sciences | |
dc.subject.classification | 3210 Nutrition and dietetics | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive | |
dc.subject.mesh | Lung | |
dc.subject.mesh | Pneumonia | |
dc.subject.mesh | Inflammation | |
dc.subject.mesh | Carbohydrates | |
dc.subject.mesh | Lung | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive | |
dc.subject.mesh | Pneumonia | |
dc.subject.mesh | Inflammation | |
dc.subject.mesh | Carbohydrates | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive | |
dc.subject.mesh | Lung | |
dc.subject.mesh | Pneumonia | |
dc.subject.mesh | Inflammation | |
dc.subject.mesh | Carbohydrates | |
dc.title | Faecal microbial transfer and complex carbohydrates mediate protection against COPD. | |
dc.type | Journal Article | |
utslib.citation.volume | 73 | |
utslib.location.activity | England | |
utslib.for | 1103 Clinical Sciences | |
utslib.for | 1114 Paediatrics and Reproductive Medicine | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | University of Technology Sydney/Faculty of Science/School of Life Sciences | |
pubs.organisational-group | University of Technology Sydney/Strength - CFI - Centre for Inflammation | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups/Australian Institute for Microbiology & Infection (AIMI) | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups/Centre for Inflammation (CFI) | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups/Australian Institute for Microbiology & Infection (AIMI)/Associate Member | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2024-09-15T03:50:56Z | |
dc.rights.holder | © Author(s) (or their employer(s)) 2024. No commercial re-use. | |
pubs.issue | 5 | |
pubs.publication-status | Published online | |
pubs.volume | 73 | |
utslib.citation.issue | 5 |
Abstract:
OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a major cause of global illness and death, most commonly caused by cigarette smoke. The mechanisms of pathogenesis remain poorly understood, limiting the development of effective therapies. The gastrointestinal microbiome has been implicated in chronic lung diseases via the gut-lung axis, but its role is unclear. DESIGN: Using an in vivo mouse model of cigarette smoke (CS)-induced COPD and faecal microbial transfer (FMT), we characterised the faecal microbiota using metagenomics, proteomics and metabolomics. Findings were correlated with airway and systemic inflammation, lung and gut histopathology and lung function. Complex carbohydrates were assessed in mice using a high resistant starch diet, and in 16 patients with COPD using a randomised, double-blind, placebo-controlled pilot study of inulin supplementation. RESULTS: FMT alleviated hallmark features of COPD (inflammation, alveolar destruction, impaired lung function), gastrointestinal pathology and systemic immune changes. Protective effects were additive to smoking cessation, and transfer of CS-associated microbiota after antibiotic-induced microbiome depletion was sufficient to increase lung inflammation while suppressing colonic immunity in the absence of CS exposure. Disease features correlated with the relative abundance of Muribaculaceae, Desulfovibrionaceae and Lachnospiraceae family members. Proteomics and metabolomics identified downregulation of glucose and starch metabolism in CS-associated microbiota, and supplementation of mice or human patients with complex carbohydrates improved disease outcomes. CONCLUSION: The gut microbiome contributes to COPD pathogenesis and can be targeted therapeutically.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph